Abstract
<p>Microfluidics plays a pivotal role in advancing lab-on-a-chip technologies, offering the potential to create bulk nanobubbles for therapeutic applications. However, the utilization of microfluidics for this purpose has been limited. This dissertation introduces innovative microfluidic techniques aimed at producing uniform bulk nanobubbles and sub-10 μm microbubbles.</p> <p>In the first dissertation objective, I harnessed microbubble shrinkage to create uniform sub-10 μm microbubbles via microfluidic flow-focusing. Microbubbles typically contract as gas escapes and dissolves after formation. I investigated the influence of gas type, concentration, lipid content, and initial microbubble size on shrinkage. Results showed that adjusting lipid concentration and initial microbubble diameter allows precise control over final bubble size. Results from the first objective highlight a key finding: the size range of biomedical microbubbles is no longer limited by the microfluidic orifice width. Instead, the concentration of lipids can now be employed to regulate their diameters. I discovered that using the lipid solution in this thesis requires microbubbles' initial diameter under 10 μm to produce bulk nanobubbles.</p> <p>The second dissertation objective involved optimizing microfluidic flow-focusing to create bulk nanobubbles. This new technique produced nanobubbles with diameters of 170 – 260 nm. Notably, a critical initial microbubble diameter was identified, below which shrinkage behavior significantly altered. Larger initial microbubbles shrank to a stable size as seen earlier. However, those smaller than the critical diameter unexpectedly contracted into nanobubbles, much smaller than anticipated.</p> <p>For the third objective of this dissertation, I presented a new microfluidic technique to generate bulk nanobubbles whose concentrations were more than 23 times higher than those of the flow- focusing bulk nanobubbles. This microfluidic method can generate bubbles with starting diameters of 2 – 10 μm (below the critical diameter discovered in objective 2) that reduce to 100 – 140 nm following shrinking. Bulk nanobubbles created using this approach are more monodisperse than those produced using the flow-focusing method. I expect the new techniques in this thesis to enable controlled and uniform microfluidic production of bulk nanobubbles and microbubbles for diverse applications.</p>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.